Healthcare - Biotechnology - NASDAQ - US
$ 22.82
5.7 %
$ 546 M
Market Cap
-7.61
P/E
BALANCE SHEET
694 M
ASSETS
236 M
LIABILITIES
464 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
PureTech Health plc
| Current Assets | 347 M |
| Cash & Short-Term Investments | 327 M |
| Receivables | 2.38 M |
| Other Current Assets | 17.7 M |
| Non-Current Assets | 347 M |
| Long-Term Investments | 326 M |
| PP&E | 19.4 M |
| Other Non-Current Assets | 1.78 M |
| Current Liabilities | 51.4 M |
| Accounts Payable | 14.6 M |
| Short-Term Debt | 7.09 M |
| Other Current Liabilities | 29.6 M |
| Non-Current Liabilities | 184 M |
| Long-Term Debt | 18.2 M |
| Other Non-Current Liabilities | 166 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Cash & Cash Equivalents | 191.1 | 149.9 | 465.7 | 403.9 | 132.4 | 117.1 | 72.6 | 63.0 | 134.8 | 219.0 | 7.2 | 10.9 |
| Short Term Investments | 136.1 | 200.2 | (1.3) | (1.7) | 30.1 | 133.8 | 117.0 | 219.4 | 179.8 | 1.2 | 1.8 | 1.2 |
| Receivables | 2.4 | 12.3 | 3.6 | 2.9 | 2.3 | 1.3 | 1.8 | 0.1 | 0.6 | 0 | 0 | 0 |
| Inventory | 0 | 1 | 28.0 | 7.5 | 1 | (1.3) | (2.7) | (1.9) | 1 | (1.7) | (2.7) | 1 |
| Other Current Assets | 17.7 | 23.8 | 32.5 | 7.5 | 4.1 | 7.6 | 7.6 | 6.6 | 3.9 | 3.6 | 3.1 | 1.5 |
| Total Current Assets | 347.2 | 386.2 | 501.8 | 414.3 | 168.8 | 259.8 | 198.1 | 288.2 | 318.2 | 223.7 | 12.1 | 13.5 |
| PP&E | 19.4 | 37.2 | 43.9 | 42.9 | 43.8 | 8.3 | 6.9 | 6.9 | 4.5 | 1.2 | 1.2 | 1.1 |
| Intangible Assets | 0.9 | 0.8 | 1.0 | 0.9 | 0.6 | 3.1 | 3.3 | 3.5 | 3.9 | 3.0 | 3.2 | 3.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 325.6 | 60.8 | 398.5 | 531.9 | 695.5 | 35.9 | 14.3 | (219.3) | (179.7) | (1.1) | (1.6) | 40 K |
| Other Long Term Assets | 0.9 | 278.4 | 399.3 | 531.9 | 32.3 | 134.2 | 117.1 | 65 K | 57 K | 5 K | 3 K | 9 K |
| Other Assets | 0 | 1 K | 0 | 1 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 694.0 | 702.6 | 946.0 | 990.0 | 941.2 | 441.8 | 339.8 | 298.7 | 326.8 | 228.0 | 16.8 | 19.2 |
| LIABILITIES | ||||||||||||
| Accounts Payable | 14.6 | 26.5 | 11.3 | 8.9 | 11.1 | 4.6 | 3.4 | 2.1 | 2.4 | 1.6 | 0.9 | 1.2 |
| Short Term Debt | 7.1 | 12.5 | 9.4 | 29.7 | 4.4 | (18.8) | (121.6) | (81.4) | (82.1) | (63.3) | (3.2) | 1.5 |
| Other Current Liabilities | 29.6 | 57.9 | 205.3 | 141.1 | 123.7 | 218.3 | 134.0 | 106.7 | 66.1 | 14.9 | 10.1 | 12.5 |
| Total Current Liabilities | 51.4 | 96.9 | 226.1 | 180.9 | 139.2 | 265.8 | 273.9 | 204.1 | 160.5 | 93.7 | 22.8 | 21.4 |
| Long Term Debt | 18.2 | 34.4 | 43.3 | 46.9 | 34.9 | 0.7 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 52.5 | 19.6 | 89.8 | 108.6 | 115.4 | 6.4 | 4.4 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 113.7 | 4.1 | 2.7 | 0 | 0 | 0.9 | 1.4 | 2.1 | 1.9 | 0.1 | 0.5 | 48 K |
| Total Liabilities | 235.7 | 155.1 | 361.9 | 336.5 | 290.8 | 274.8 | 275.8 | 206.3 | 162.7 | 94.3 | 24.8 | 22.5 |
| EQUITY | ||||||||||||
| Common Stock | 5.5 | 5.5 | 5.4 | 5.4 | 5.4 | 5.4 | 4.7 | 4.6 | 4.5 | 159.4 | 1.3 | 1.3 |
| Retained Earnings | 222.3 | 149.5 | 199.9 | 260.4 | 254.4 | (167.7) | (127.9) | (160.3) | (111.4) | (70.4) | (35.1) | (30.9) |
| Other Accumulative Comprehensive Income/Loss | 129.1 | (14.4) | (39.6) | (23.6) | (18.3) | (6.1) | (3.9) | (2.2) | (1.1) | (0.6) | (0.5) | (0.3) |
| Total Equity | 458.2 | 547.6 | 584.1 | 653.5 | 650.4 | 167.0 | 64.0 | 92.4 | 164.1 | 133.7 | (8.0) | (3.4) |
| Total Liabilities and Equity | 694.0 | 702.6 | 946.0 | 990.0 | 941.2 | 441.8 | 339.8 | 298.7 | 326.8 | 228.0 | 16.8 | 19.2 |
| SHARES OUTSTANDING | ||||||||||||
| Common Shares Outstanding | 27.6 | 279.7 | 286.6 | 299.3 | 292.5 | 272.8 | 240.7 | 229.5 | 185.3 | 81.7 | 53.8 | 63.3 |